ActiveCare+SFT Hemodynamic Profile Compare to SCD Express in Ventilated Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2006 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00338819
First received: June 18, 2006
Last updated: NA
Last verified: June 2006
History: No changes posted
  Purpose

Purpose:

To test the hemodynamic profile generated by the MCS’s ActiveCare+SFT device in ventilated patients and compare it to that of the Kendall SCD Express.

Design:

Comparative, prospective study. Patients are their own controls.


Condition
DVT Prevention
Ventilated Patients

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Cross-Sectional
Official Title: ActiveCare+SFT Hemodynamic Profile Compare to SCD Express in Ventilated Patients

Further study details as provided by Tel-Aviv Sourasky Medical Center:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adult ventilated patient (Age >18).
  • The patient or his guardian is able and voluntarily prepared to sign the Informed Consent Form.

Exclusion Criteria:

  • Known, preexisting DVT or PE.
  • Patient who is participating in another clinical trial.
  • Patient with contraindication to use of the device including patients with leg gangrene, recent skin graft or medical situations where increase venous and lymphatic return is undesirable.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00338819

Contacts
Contact: Sorkine, Prof 972-3-6973894 sorkine@tasmc.health.gov.il

Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Investigators
Principal Investigator: Sorkine, Prof Tel-Aviv Sourasky Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00338819     History of Changes
Other Study ID Numbers: TASMC06SP156CTIL
Study First Received: June 18, 2006
Last Updated: June 18, 2006
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Tel-Aviv Sourasky Medical Center:
DVT prevention
Hemodynamic study
IPC
CECT

ClinicalTrials.gov processed this record on July 31, 2014